The problem is solved by a peritoneal dialysis fluid containing substances selected from cyclonigerosyl nigerose.
含有黑曲霉糖的腹膜透析液能够解决这个问题。
The object is solved by a peritoneal dialysis fluid containing one or more substances selected from cyclonigerosyl nigerose, cyclomaltosyl maltose and L-ascorbic acid 2-glucoside.
该技术问题通过提供含有一种或两种以上选自环黑曲霉 糖基黑曲霉糖、环麦芽糖基麦芽糖以及L-抗坏血酸2-葡萄糖苷的腹膜透析液得 到解决。
An object of the invention is to provide a peritoneal dialysis fluid, which is excellent in a water removal ability, has high biocompatibility, and is excellent in storage stability.
本发明要解决的技术问题是提供一种脱水性良好、生物适应性高和存储稳定性好的腹膜透析液。
Objective To study the effect of salt and water restriction on fluid status in diabetic peritoneal dialysis patients.
目的探讨限制水盐摄入对糖尿病腹膜透析患者容量负荷状况的影响。
Objective to study the effect of the salt and water restriction combined with diuretics therapy on fluid status in patients on continuous ambulatory peritoneal dialysis (CAPD).
目的观察水盐限制联合利尿治疗对CAPD患者容量超负荷的疗效。
Objective to study the effect of the salt and water restriction combined with diuretics therapy on fluid status in patients on continuous ambulatory peritoneal dialysis (CAPD).
目的观察水盐限制联合利尿治疗对CAPD患者容量超负荷的疗效。
应用推荐